跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13 条关于
“Indaptus”
全部
13
临床试验
0
药物
0
机构
2
资讯
11
去年
Indaptus Therapeutics and BeiGene Collaborate on Novel Cancer Immunotherapy Combination
去年
Incyte and Indaptus Announce Key Milestones and Strategic Goals for 2025
去年
Indaptus Therapeutics Advances Decoy20 Clinical Trial and Enters Supply Agreement with BeiGene
去年
Indaptus Therapeutics Reports Partial Response with Decoy20 in Urothelial Cancer Patient
3个月前
Indaptus Therapeutics Halts Decoy20 Development, Pivots to Strategic Review After $12 Million Financing
去年
Health Canada Approves Expansion of Decoy20 Cancer Immunotherapy Trial
去年
Leading Biotech Companies to Convene at 6th Cytokine-Based Drug Development Summit 2025 in Boston
去年
Indapta and Sanofi Collaborate to Evaluate g-NK Cell Therapy with Sarclisa in Multiple Myeloma
去年
Indapta Therapeutics Raises $22.5 Million to Advance NK Cell Therapy
去年
Indapta's IDP-023 Shows Promise in Multiple Myeloma and Enhanced NK Cell Activity
第 1 页,共 2 页
上一页
下一页